Search
for
Sort by
Research 211–240 of 1000+
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
- How should postmenopausal androgen excess be evaluated?
- The diagnosis of polycystic ovary syndrome in adolescents
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
- Female pattern hair loss
- Lipid Profile and Metabolic Syndrome Status in Patients with Oral Lichen Planus, Oral Lichenoid Reaction and Healthy Individuals Attending a Dental College in Northern India - A Descriptive Study
- Eficácia Do Minoxidil Tópico E Oral No Tratamento Da Alopecia Androgenética
- TERAPIA ORAL OU TÓPICA? REVISÃO INTEGRATIVA SOBRE O USO DE MINOXIDIL NA ALOPECIA ANDROGENÉTICA
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Epicardial fat thickness in children with classic congenital adrenal hyperplasia
- Relationship of androgenic alopecia with higher BMI in Pakistan: A cross sectional study
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- A Gender Hypothesis of sex disparities in adverse drug events
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Hair loss and cardiovascular health
- Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study
- Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study
- Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Forensic approach in cases of anabolic-androgenic steroid abuse and cardiovascular mortality: insights from autopsy, histopathology, immunohistochemistry and toxicology
- Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US
- Assessment of cardiovascular risk in patients with androgenetic alopecia using high-sensitivity C-reactive protein and lipoprotein a
- Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides
- Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with self-reported premenopausal hirsutism and/or oligo-amenorrhea
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system